These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31082855)

  • 1. Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease.
    Ivancovsky-Wajcman D; Zelber-Sagi S; Fliss Isakov N; Webb M; Zemel M; Shibolet O; Kariv R
    Clin Transl Gastroenterol; 2019 May; 10(5):1-10. PubMed ID: 31082855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Kolodkin-Gal I; Erez N; Buch A; Yeshua H; Webb M; Halpern Z; Shibolet O
    Dig Liver Dis; 2017 May; 49(5):523-529. PubMed ID: 28179090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance.
    Zelber-Sagi S; Ivancovsky-Wajcman D; Fliss Isakov N; Webb M; Orenstein D; Shibolet O; Kariv R
    J Hepatol; 2018 Jun; 68(6):1239-1246. PubMed ID: 29571924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.
    Laudenslager M; Lazo M; Wang D; Selvin E; Chen PH; Pankow JS; Clark JM
    Dig Liver Dis; 2021 Jul; 53(7):873-878. PubMed ID: 33640303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
    Martin-Rodriguez JL; Gonzalez-Cantero J; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
    Medicine (Baltimore); 2017 Apr; 96(17):e6770. PubMed ID: 28445310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study.
    Meng G; Liu F; Fang L; Li C; Zhang Q; Liu L; Wu H; Du H; Shi H; Xia Y; Guo X; Liu X; Bao X; Su Q; Gu Y; Yu F; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Guo Q; Chen X; Song K; Wang G; Huang G; Niu K
    Ann Med; 2016 Nov; 48(7):568-576. PubMed ID: 27649339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
    Atsawarungruangkit A; Chenbhanich J; Dickstein G
    World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
    Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
    Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
    Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.
    Wang R; Lu Q; Feng J; Yin F; Qin C; Liu B; Liu Y; Liu X
    Endocrine; 2012 Feb; 41(1):70-5. PubMed ID: 21796479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.